Dr. Mark Adler, Institute Director, heads the Molecular Oncology Diagnostics and Second Opinion Initiative, a new generation-platform for developing treatments tailored to the individual patient. It involves the application of sensitive molecular tests to the determination of a tumor's drug sensitivity and resistance. In addition a person's hereditary traits and a tumor's genetic signature will be used to determine how best to eliminate a given cancer with a specific therapy or agent.

INTEGRATIVE MEDICINE PROGRAM

Integrative medicine in oncology care combines multiple treatment modalities and support to create a total healing environment and encourages the patient to become an active agent in his or her care and wellness. Modern drug therapies are complemented with integrative approaches including:

- Mind / Body Research
- Immune System Enhancement
- Intention and Intuition
- Patient Support Groups
- Meditation / Relaxation
- Massage Therapy
- Nutrition
- Emotional Well Being
- Energy Medicine
- Reiki
- Qi-gong
- Acupuncture
- Exercise / Yoga

CLINICAL TRIALS

Carefully designed clinical studies translate results of basic science research into better ways to prevent, diagnose and treat cancer. Despite the importance of participation in clinical trials, typically only 3-5% of patients are enrolled.

The SDCRI is committed to sharing with patients the latest information about treatment options and providing them the opportunity to receive the best possible care by participating in clinical trials